跳至主要内容
临床试验/NCT00427778
NCT00427778终止不适用

The Treatment of Stress Urinary Incontinence Using an Incontinence Ring: A Randomized, Cross-over Trial

Queen's University2 个研究点 分布在 1 个国家目标入组 29 人开始时间: 2006年6月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
29
试验地点
2
主要终点
Number of Participants With 50% or More Reduction in Number of Incontinence Episode Per Week

研究概览

简要总结

This study aims as defining success rate of the incontinence ring in women with test proven stress urinary incontinence and determining factors associated with successful use.

详细描述

The primary objective of this study is to determine if the incontinence ring is effective in decreasing the incontinence episode frequency per week. Other objectives include the determination of the cure rate (objective and subjective) with the ring, the effects to bladder function as noted on urodynamic testing, the impact on quality of life and the acceptability to this device in the treatment of stress urinary incontinence.

In this cross-over study, 40 women will undergo a two-period treatment. In one of the periods, she will spend 4 weeks wearing continuously the ring and in the other (also 4 weeks duration), she will not be using any treatment for her incontinence. Between periods, she will spend 2 weeks in "wash out" to eliminate the risk of continuous effect from the treatment in the preceding period. Each woman will be randomly assigned to the treatment sequence.

Stress urinary incontinence is a common problem affecting at almost 20% of women. Treatments currently advocated include pelvic floor exercises and surgery. Pelvic floor exercises require great motivation and usually 3 months of training to show an impact. Surgery is very effective, but costly and carries a number of complications. The use of the incontinence ring may allow women to control their symptoms with immediate result at minimal risk. This device has never been properly evaluated before its introduction into the market.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Symptoms of urinary stress urinary incontinence (i.e. urinary leakage associated with increased intra-abdominal pressure/cough) (if mixed incontinence the urinary stress urinary incontinence symptoms must predominate)
  • Urodynamic Stress urinary incontinence confirmed by urodynamic studies (i.e. urinary leakage associated with increased intra-abdominal pressure/cough in the absence of detrusor overactivity)
  • Ability to understand spoken and written English

排除标准

  • Severe pelvic organ prolapse (> or = stage 3 on the Pelvic Organ Prolapse Quantification System - POP-Q)
  • Contraindications to pessary use (including acute vaginal/urinary or pelvic infections, vaginal or cervical lesions or unexplained vaginal bleeding)
  • Inability to properly fit the incontinence ring

结局指标

主要结局

Number of Participants With 50% or More Reduction in Number of Incontinence Episode Per Week

时间窗: baseline and 4 weeks

number of women who experienced 50% or more reduction in number of incontinence episode per week on diary while using the incontinence ring, compared to baseline period.

次要结局

  • Objective Cure Rate(4 weeks)
  • Patient Acceptability (10 cm VAS)(4 weeks)
  • Post Void Residual(The UDS while wearing the ring was done 2-4 weeks into the 'ring' treatment period, at patient's convenience, the UDS done at baseline was considered representative of "no treatment" UDS.)
  • Score on Question 3 of UDI 6(4 weeks)
  • UDI Overall Score(4 weeks)
  • Urodynamic Effect of the Incontinence Ring on Flow Rate(baseline and at 4 weeks of ring use.)
  • Impact on I-QOL(4 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr. Marie-Andree Harvey

Principal Investigator

Queen's University

研究点 (2)

Loading locations...

相似试验